<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Posttransplant <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (PTLD) are a rare, but serious complication following transplantation </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003584'>Late-onset</z:hpo> PTLD are often associated with more monoclonal lesions and consequently have a worse prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>There are only isolated case reports of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presenting as PTLD </plain></SENT>
<SENT sid="3" pm="."><plain>We present an extremely rare, aggressive Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> years after kidney and pancreas transplantation which was successfully treated with combination chemotherapy along with withdrawal of immunosuppression </plain></SENT>
<SENT sid="4" pm="."><plain>The patient remains in complete remission more than 2 years after his diagnosis </plain></SENT>
<SENT sid="5" pm="."><plain>We also provide a succinct review of treatment of various PTLD and discuss the role of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> in the pathogenesis of PTLD </plain></SENT>
</text></document>